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Abstract: Protein hydrolysates show great promise as bioactive food and feed ingredients and for
valorization of side-streams from e.g., the fish processing industry. We present a novel approach
for hydrolysate characterization that utilizes proteomics data for calculation of weighted mean
peptide properties (length, molecular weight, and charge) and peptide-level abundance estimation.
Using a novel bioinformatic approach for subsequent prediction of biofunctional properties of
identified peptides, we are able to provide an unprecedented, in-depth characterization. The study
further characterizes bulk emulsifying, foaming, and in vitro antioxidative properties of enzymatic
hydrolysates derived from cod frame by application of Alcalase and Neutrase, individually and
sequentially, as well as the influence of heat pre-treatment. All hydrolysates displayed comparable
or higher emulsifying activity and stability than sodium caseinate. Heat-treatment significantly
increased stability but showed a negative effect on the activity and degree of hydrolysis. Lower degrees
of hydrolysis resulted in significantly higher chelating activity, while the opposite was observed
for radical scavenging activity. Combining peptide abundance with bioinformatic prediction,
we identified several peptides that are likely linked to the observed differences in bulk emulsifying
properties. The study highlights the prospects of applying proteomics and bioinformatics for
hydrolysate characterization and in food protein science.
Keywords: codfish; enzymatic hydrolysis; proteomics; bioinformatic prediction; emulsifying properties;
antioxidative activity; bioactive peptides
1. Introduction
Approximately 60% of fish processing byproducts are discarded in the sea or used as fishmeal,
fish oil, fertilizer, fish silage, and animal feed [1]. Fish frame is the major side stream from fish
processing plants, which comprise about 22% solids and considerable amounts of proteins and
minerals. This means high disposal costs for the processors and a negative value for the industry.
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However, the increasing demand for protein on a global scale turns the focus on underutilized protein
sources such as cod (Gadus morhua) frame. Cod frame side-streams can be considered as a steady and
valuable source of not only minerals such as calcium and phosphorus, but also protein and potentially
bioactive peptides (BAPs) [2]. Cheung et al. reviewed recent studies on the utilization of marine
species by enzymatic hydrolysis for the recovery of various valuable components [3]. For instance,
fish protein hydrolysates (FPH) from cod frames have been shown to possess functional and antioxidant
activities [4–6].
Proteolytic conversion of proteins into bioactive peptides has become an integral part of the food
processing industry and has many advantages. The creation of new nutraceuticals and functional
food ingredients can promote the health level of society and/or improve the functional and rheological
properties of food products [7]. The application of proteolytic enzymes has been broadly considered as
the most practical approach for the release of BAPs from fish protein [8,9]. To obtain highly functional
BAPs, it is necessary to optimize the hydrolyzation process [10]. The use of different types of proteases,
substrates (different fish species/flesh/frame/viscera), and several other variables such as pH, time,
and temperature have been extensively investigated [11].
Studies on identification of the generated peptides from fish proteins as a function of the proteases
type are scarce [12,13] and there is no report specifically in the case of cod frame. Consequently,
this study was performed to increase the knowledge of practical short-term hydrolysis of cod frame by
two industrial proteases: Alcalase and Neutrase, either individually or sequentially. The efficiency of
the selected proteases was assessed in terms of the degree of hydrolysis (DH), and the composition
of hydrolysates was characterized using mass spectrometry (MS)-based proteomics. The obtained
hydrolysates were characterized with respect to their emulsifying and antioxidative properties.
In addition, bioinformatics tools were used to predict the emulsifying and antioxidative properties
of the most abundant peptides from cod frame, as determined by MS. Combining the application
of proteomics and bioinformatics tools has been suggested to be an effective approach in early
stage identification of embedded bioactive peptides in order to design a protocol for hydrolysis
(e.g., using enzymes with the appropriate specificity) and further purification of the hydrolysate,
saving costs and time of extensive screening processes [14]. Thus, by combining quasi-quantitative
identification of peptides with predicted functionality using bioinformatics, we aimed to identify the
BAPs responsible for the bulk properties observed in the FPHs.
2. Results and Discussion
2.1. Proteolysis Efficiency
The degree of hydrolysis (i.e., percentage of cleaved peptide bonds) is a true reflection of the
progress of hydrolysis and thus its selection as the primary indicator for controlling or measuring
the extent of hydrolysis is very appropriate. As shown in Table 1, the application of proteases,
either individually or sequentially applied to cod frame, resulted in DH between about 19% and
39% (p < 0.05). The highest DH was obtained by sequential enzyme treatment of MCF while the
lowest DH was obtained with Neut on HCM. The measured DH range corresponds well with previous
reports on short-term hydrolysis of cod frame using Protamex. Alc hydrolysis on both MCF and HCM
substrates showed higher efficiency i.e., higher DH compared to Neut hydrolysis. This is confirmed by
both tricine SDS-PAGE analysis in Figure 1 and gradient SDS-PAGE analysis (Figure S1), where Neut
hydrolysates (lanes 2 and 5) show a larger proportion of higher more molecular weight (MW) peptides
compared to both Alc (lanes 1 and 4) and sequential (lanes 3 and 6) hydrolysates. When looking
at SDS-PAGE staining, it should be kept in mind that response is mass-dependent and hence not
stochastic. This means that, in principle, there has to be ten times more of the number of e.g., a 500 Da
peptide to produce the same response as one equivalent of a 5 kDa peptide. The observation is not
surprising though, as Alc (which mainly consist of subtilisin A) shows very broad specificity towards
bulky and uncharged amino acids (AAs) [15].
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Table 1. Bulk characterization of functional properties in fish protein hydrolysates (FPH). Degree of hydrolysis (DH), emulsification activity index (EAI), emulsification
stability index (ESI), foaming capacity (FC), foaming stability (FS), DPPH radical scavenging activity, and metal chelating activity of FPH from minced cod frame
(MCF) and heated cod meat (HCM) by application of Alcalase and Neutrase separately or sequentially. For comparison, sodium caseinate (SC) was used as control.
N/A: Not applicable (SC was used as is).
Substrate Treatment DH (%) * EAI (m2/g) * ESI (min) * FC (%) FS (%)
DPPH RSA
(IC50 mg/mL) *
Fe2+ MCA
(IC50 mg/mL) *
MCF
Neutrase 27.0 ± 0.12 d 80.75 ± 4.32 ab 33.39 ± 0.56 cd 40 88 4.36 ± 0.08 b 0.53 ± 0.013 c
Alcalase 36.1 ± 0.03 b 88.18 ± 7.94 a 29.38 ± 3.52 d 30 87 4.97 ± 0.18 a 0.77 ± 0.03 bc
Neutrase & Alcalase 39.2 ± 0.04 a 87.54 ± 4.46 a 36.10 ± 5.12 c 4 100 4.31 ± 0.06 b 0.77 ± 0.03 bc
HCM
Neutrase 18.7 ± 0.09 e 66.41 ± 0.97 c 46.82 ± 4.75 b 54 37 3.36 ± 0.18 c 0.69 ± 0.02 c
Alcalase 30.2 ± 0.05 c 68.35 ± 0.72 c 65.15 ± 2.03 a 23 78 3.58 ± 0.21 c 1.01 ± 0.31 b
Neutrase & Alcalase 30.2 ± 0.04 c 76.48 ± 3.99 b 45.70 ± 1.94 b 6 100 2.93 ± 0.05 d 1.65 ± 0.07 a
Control (SC) - N/A 64.48 ± 3.33 c 15.86 ± 1.15 e N/A N/A N/A N/A
Different small superscript letters in each column indicate the significant differences among means at 95 confidence level (α = 0.05). * Mean ± SD. All data are based on three replicates.
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Figure 1. SDS-PAGE of FPH samples on 16.5% Tris-Tricine gels. (A) 20 μg protein/peptide [2]; (B) 200 
μg protein/peptide [2]. L (MW marker), 1 (MCF-Alc), 2 (MCF-Neut), 3 (MCF-Neut&Alc), 4 (HCM-
Alc), 5 (HCM-Neut) and 6 (HCM-Neut&Alc). 
Neut, on the other hand, mainly prefers leucine and phenylalanine specifically [15]. As both AAs 
are bulky and uncharged, they are also targeted by Alc. Higher activity of Alc compared to Neut at 
the same E/S ratio is also in line with other studies [16]. The overlap in specificity may also explain 
why very low increase in DH is observed for sequential hydrolysis of MCF, while no significant 
increase in DH is observed for HCM (Table 1). Based on DH, both proteases display substrate 
preference towards MCF, an observation not readily observable from SDS-PAGE analysis (Figure 1). 
Considering that HCM is a heat-denatured substrate, formation of protein aggregates may decrease 
accessibility thereby decreasing DH for HCM. Although the boiling of the cod frame was done well 
below the decomposition temperatures of Phe (>200 °C) [17], thermally induced oxidation of aromatic 
AAs, hereunder Phe, is a well-documented phenomenon [18]. Furthermore, Phe has also been 
reported to trigger protein aggregation at elevated temperatures [19,20]. Consequently, as Phe and 
other thermally oxidized AAs are altered or become inaccessible from heating, it is speculated that 
the number of proteolytic sites have been reduced. This also explains why the effect of boiling is more 
pronounced for Neu than Alc (relative decrease in DH of 30% and 16%, respectively). When 
considering the AA composition of the cod frame substrate, the relative decrease of 30% in DH for 
Neut corresponds perfectly with the amount of Phe relative to the amount of Phe and Leu combined 
[2]. 
To make the hydrolysis process more industrially and economically applicable, the enzyme was 
added based on its weight relative to the protein concentration of the initial substrate, and not based 
on declared enzymatic activity per enzyme mass. This means that Alc was applied in a three times 
higher activity than Neut (2.4 AU/g vs. 0.8 AU/g, respectively). This factor should also be regarded 
when comparing hydrolysis efficiency, and, therefore, the prerequisite for proper comparison 
between these two enzymes is to administrate them with the same activity as done in a study 
conducted by Liaset et al. [21]. The authors reported that by application of Alc and Nuet at 30 AU/g 
of cod backbone, no significant differences were observed in terms of DH after 60 and 120 min of 
enzymatic hydrolysis process. Nevertheless, the difference in specificity will also be reflected in the 
resulting hydrolysate and consequently also the properties hereof. 
When comparing DH between studies as the main variable, several factors must be considered. 
Apart from enzyme specificity, variation in DH can be attributed to other experimental variables such 
as substrate types, testing conditions (time, temperature, pH, E/S ratio, etc.), seasonal variation and 
catchment region [22]. In addition, evaluating the hydrolysis efficiency by DH is done in 
Figure 1. SDS-PAGE of FPH samples on 16.5% Tris-Tricine gels. (A) 20 µg protein/peptide [2]; (B) 200 µg
protein/peptide [2]. L (MW marker), 1 (MCF-Alc), 2 (MCF-Neut), 3 (MCF-Neut&Alc), 4 (HCM-Alc),
5 (HCM-Neut) and 6 (HCM-Neut&Alc).
Neut, on the other hand, mainly prefers leucine and phenylalanine specifically [15]. As both AAs
are bulky and uncharged, they are also targeted by Alc. Higher activity of Alc compared to Neut at the
same E/S ratio is also in line with other studies [16]. The overlap in specificity may also explain why
very low increase in DH is observed for sequential hydrolysis of MCF, while no significant increase in
DH is observed for HC (Table 1). Based o DH, both prote s s display substrate preference towards
MCF, an observa ion not readily observable from SDS-PAGE analysis (Fi ure 1). Considering that
HCM is a heat-denatured substrate, formation of protein aggregates may decrease accessibility thereby
decreasing DH for HCM. Although the boiling of the cod frame was done well below the deco position
temperatures of Phe (>200 ◦C) [17], thermally induced oxidation of aromatic AAs, hereunder Phe,
is a well-documented phenomenon [18]. Furthermore, Phe has also been reported to trigger protein
aggregation at elevated temperatures [19,20]. Consequently, as Phe and other thermally oxidized AAs
are altered or become inaccessible from heating, it is speculated that the number of proteolytic sites
have been reduced. This also explains why the effect of boiling is more pronounced for Neu than Alc
(relativ dec ease in DH of 30% and 16%, respectively). When considering the AA composition of
the cod frame substrate, the relative decrease of 30% in DH for Neut corresponds perfectly with the
amount of Phe relative to the amount of Phe and Leu combined [2].
To make the hydrolysis process more industrially and economically applicable, the enzyme was
added based on its weight relative to the protein concentration of the initial substrate, and not based
on declared enzymatic activity per enzyme mass. This means that Alc was applied in a three times
higher activity than Neut (2.4 AU/g vs. 0.8 AU/g, respectively). This factor should also be regarded
when comparing hydrolysis efficiency, and, therefore, the prerequisite for proper comparison between
these two enzymes is to administrate them with the same activity as done in a study conducted by
Liaset et al. [21]. The autho s r port d that by applicatio of Alc and Nuet at 30 AU/g of co backbone,
no significa t differences were observed in terms of DH after 60 and 120 min of enzymatic hydrolysis
process. Nev rtheless, the difference in sp cificity will also e reflected in the resulting hydrolysate
and consequently also the properties hereof.
When comparing DH between studies as the main variable, several factors must be considered.
Apart from enzyme specificity, variation in DH can be attributed to other experimental variables such
as substrate types, testing conditions (time, temperature, pH, E/S ratio, etc.), seasonal variation and
catchment region [22]. In addition, evaluating the hydrolysis efficiency by DH is done in fundamentally
different ways, which will influence the result [23]. Amongst the most popular are pH stat [24],
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soluble nitrogen in aqueous trichloroacetic acid (SN-TCA) [25], 2,4,6-trinitrobenzene 1-sulphonic
acid (TNBS) [26], o-phthaldialdehyde (OPA) [27] and the most recent quantitative colorimetric free
α-amino-N by PicoEXPLORERTM, which was used in the current study.
2.2. Proteomics Analysis and Methodological Limitations
The distribution of peptide chain length (PCL), peptide molecular weight (PMW), and peptide
charge (Pz) is illustrated in Figure 2. Peptide properties are presented as both weighted distributions
according to their relative MS1 intensities and as unweighted distributions. Binned distributions
are illustrated in Figure S2. Mean population properties (weighted and unweighted) are presented
in Table 2. As a direct consequence of the broad distributions of all three peptide parameters and a
resultantly large standard deviation, there are no statistically significant difference between means at
a 95% confidence level using Tukey HSD. Nevertheless, both the mean properties (Table 2) and the
distributions differ. Although PCL and PMW are not directly proportional, as PMW depends on the
specific AA composition of a peptide, they follow the same trend. For PCLavg, the trend follows
the trend observed from DH determination and the mean length based hereon (PCLDH) as well as
SDS-PAGE analysis (Figure 1), where Alc&Neut was the most and Neut the least efficient.
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Figure 2. Histograms of unbinned, relative distributions for peptide chain length (A + D),
peptide molec eight (B + E), and peptide charge at pH = 7 (C + F) for fish protein hydrolysates
obtained fro minced cod frame (MCF) and heated cod meat (HCM) by enzymatic hydrolysis with
neutrase (Neut) in greys, alcalase (Alc) in blues, or sequential hydrolysis with neutrase and alcalase
(Neut&Alc) in greens. Distributions are shown for intensity-weighted data (A–C) and unweighted
data (D–F).
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Table 2. Number of identified peptides, average peptide chain length (PCLavg), average peptide molecular weight (PMWavg), and average peptide charge (Pzavg)
as determined by LC-MS/MS analysis. Mean peptide attributes are expressed as both weighted (by peptide MS1 intensity) and unweighted. PCL calculated as inverse
degree of hydrolysis (PCLDH) according to Adler-Nissen (1986) is listed for comparison [28].
Treatments Weighted Unweighted DH-based
Substrate Treatment Peptide IDs PCLavg (AAs) 1 PMWavg (Da) 1 Pzavg 1 PCLavg (AAs) 1 PMWavg (Da) 1 Pzavg 1 PCLDH (AAs) *
MCF
Neutrase 6268 17.4 ± 6.9 1921 ± 674 −2.5 ± 1.7 15.3 ± 7.1 1686 ± 726 −2.2 ± 1.9 3.7 ± 0.0 b
Alcalase 4414 13.0 ± 7.3 1343 ± 635 −0.95 ± 1.6 11.7 ± 6.5 1268 ± 636 −1.5 ± 2.0 2.8 ± 0.0 d
Neutrase & Alcalase 3702 9.36 ± 4.8 999 ± 463 −1.3 ± 1.6 10.3 ± 6.1 1128 ± 614 −1.6 ± 2.0 2.6 ± 0.0 e
HCM
Neutrase 5871 16.7 ± 7.3 1853 ± 722 −2.5 ± 1.8 14.8 ± 7.4 1635 ± 755 −2.2 ± 2.0 5.4 ± 0.0 a
Alcalase 4020 13.1 ± 7.7 1334 ± 647 −0.88 ± 1.6 11.3 ± 6.5 1228 ± 622 −1.4 ± 1.9 3.3 ± 0.0 c
Neutrase & Alcalase 4361 10.2 ± 6.6 1082 ± 591 −1.1 ± 1.6 10.6 ± 6.3 1157 ± 611 −1.5 ± 2.0 3.3 ± 0.0 c
Different small superscript letters in each column indicate the significant differences among means at 95 confidence level (α = 0.05). 1 No significant difference between means at a 95%
confidence level (α = 0.05). * Mean ± SD. All data are based on three replicates.
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Comparing PCLavg and PCLDH directly (Table 2), we observe a highly significant difference,
as PCLavg is roughly 4-fold higher than PCLDH in all cases. Besides the methodological influence for
determination of DH discussed above, there are several factors, which could explain this significant
difference. PCLDH is by definition an approximation, which does not take into account the protein
composition, and in particular the length distribution of the substrate. Furthermore, ninhydrin-based
methods are susceptible to interferences, which can lead to overestimation of DH and hence
underestimation of PCLDH [24]. Such interferences may be reactive contaminants/residuals [29],
contribution of N-termini, in addition to dibasic amino acids, (Lys and Arg) [30] and Pro [31]
contributing through their side-chain amino group. Finally, as DH is based on the α-amino-N content
in the supernatant following hydrolysis, heat inactivation, and centrifugation, it does not factor in the
protein/peptide content of the sediment, and hence does not reflect the true DH of the substrate [22].
On the other hand, PCLavg may also be overestimated. Flyability in ESI-MS proteomics describes the
ability/probability of peptides to be ionized in the gas phase and subsequently detected. Several studies
have investigated the underlying principles governing the parameter, and computational models have
been produced to estimate the highly complex and sequence dependent parameter for prediction of
high responding tryptic peptides as biomarkers in protein quantification [32–35]. Although peptide
length in general is negatively correlated with flyability thereby introducing an intensity bias towards
shorter peptides, this is not reflected in our MS data, when compared to PCLDH. On the contrary,
our data appear to show bias towards longer peptides in all cases and regardless of intensity-weighting.
Although binned data representation (Figure S2) shows a somewhat normally distributed population
of PCL, unbinned data (Figure 2) show a quite different distribution. This is particularly evident
from the unweighted distribution, i.e., the number of identified peptides at each PCL. Here, we see
a somewhat binominal distribution with one part centered around 12–13 AAs, decreasing towards
6 AAs, and then presenting a huge spike at 3–4 AAs. In order to explain this observation, it is crucial to
consider the peptide combinatorial space as a function of PCL and the computational methods used
for peptide identification and subsequent quantification.
MaxQuant [36,37] employs the Andromeda search engine for peptide identification [38]. In the
process of peptide identification, Andromeda calculates a peptide score based on the MS2 peptide
spectrum match (PSM) with a theoretical MS2 spectrum. The score is subsequently used to control the
false discovery rate (FDR) as a function of PCL. As the FDR controls the cutoff peptide score for positive
PSMs and as peptide score is furthermore influenced by both PCL and intensity [36,37,39], the length
becomes a critical factor when moving towards shorter peptides. As illustrated by the MaxQuant
developers [36], when decreasing the PCL towards 6 AAs, the peptide score distribution for the target
library and the decoy library fully coincide. As the decoy library is more densely populated at any
peptide score, this means that employing standard FDR of 1% on the peptide level will result in a very
small probability of a positive PSM and hence identification of a hexapeptide (PCL = 6), despite them
actually being present in the sample. Ultimately, this leads to a bias towards identification of longer
peptides, which has also been reported in the literature [40,41].
Decreasing the PCL even further, the situation is somewhat different. As PCL decreases, so does the
combinatorial space of possible peptides, which is shown in Table S1 for both the 20 naturally occurring
AAs and including the common variable modifications employed in data analysis (oxidation of Met
and N-terminal acetylation). With ~75,000 protein entries in the proteome composing on average
326 AAs, there are for instance over 2×107 tetrapeptides (PCL = 4). This means that the amount
of tetrapeptides cover the combinatorial space for tetrapeptides over 100-fold even after including
modification, although significant redundancy is expected. This directly implies that the search space
in the decoy library will be depleted, as most decoy peptides will be present in the target library,
which takes priority for coinciding peptides. Consequently, the peptide score distribution will be
much more densely populated and the probability of a decoy PSM will be low, thereby removing
the critical peptide score and FDR constraint observed for hexapeptides. As the PCL decreases
further, so does the combinatorial space, and hence the possible number of identifiable peptides,
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thereby explaining why the number of identified tripeptides (PCL = 3) is lower than the number of
tetrapeptides. Together, the two factors describe the binominal distributions observed for particularly
unweighted PCL. Consequently, a “grey zone” at lower PCL (3–10 AAs) arises, where there is likely to
be a large number of missing peptide identifications. As the analysis furthermore does not include
free AAs and dipeptides due to the high noise in the low m/z range and the lack of MS2 evidence
to provide PSMs, this ultimately makes the method significantly biased towards longer peptides,
particularly for hydrolysates with high DH. In the end, this also means that the distributions and
calculated means are likely overestimated and do unfortunately not reflect the actual distribution
of peptides in the sample. The “grey zone” is also reflected in the number of identified peptides
(Table 2). Theoretically, the number of different peptides should increase with increasing DH until a
certain point. However, we observe the opposite trend. Nevertheless, as either increasing DH results
in an increasing proportion of peptides of a length in the “grey zone” or hydrolyzed to dipeptides
or free AAs, the combinatorial space also decreases (Table S1), and the observed trend may in fact
be a combination of both missing identifications and combinatorial space reduction. Nevertheless,
more than 14 of the identified peptides for sequential hydrolysis are tetrapeptides (Figure 2B) for both
substrates indicating a high DH in these FPHs.
Using LC-MS/MS to identify peptides in hydrolysates is far from novel [42]. In most cases,
this results in identification of multiple peptides, and the most abundant by MS1 intensity
are subsequently reported as likely to be the source of the observed activity. Nevertheless,
protein hydrolysates are highly complex mixtures of peptides identifying the highest responder
may not identify the species responsible for the observed in vitro property. Instead, bulk properties
are in fact the cumulative properties of all peptides in the hydrolysate. Nevertheless, highly abundant
peptides may significantly govern the bulk property. Consequently, we described the mean properties
of the hydrolysate here in terms on length, MW, and charge by introducing intensity-weighted means
along with stochastic means (Table 2). By applying weights, we also significantly alter the distribution
(Figure 2 and Figure S2). This is done using the assumption that high responders are highly abundant,
and thus describe the mean population of a hydrolysate more satisfactory. Although still not statistically
significantly different due to the large standard deviations, the difference between means is also larger,
thereby better reflecting the differences between treatments observed using α-amino-N and SDS-PAGE
analysis. Although intrinsic, sequence-specific properties such as flyability influence the intensity of a
given peptide, we believe that weighted distributions and means are better descriptors. Regardless,
there remains a large methodological gap for sequence-dependent correlation of MS1 intensity and
absolute abundance for non-tryptic peptides.
2.3. Interfacial Properties
2.3.1. Bulk Emulsifying Properties
Table 1 shows the EAI and ESI of FPHs from cod frame by Neut and Alc, individually or
sequentially, and sodium caseinate (SC) as the control. By comparing within group data, it is noticeable
that application of Neut and Alc separately on either MCF or HCM did not cause a significant difference
in emulsifying properties, while their sequential administration on the HCM increased the EAI although
lowering ESI, significantly (p < 0.05). However, both substrates revealed significantly higher ESI
compared to sodium caseinate (SC) and MCF also had significantly higher EAI than SC (p < 0.05).
Overall, we observe a positive relation between DH and emulsifying properties, i.e., the higher DH
and hence lower PCL, the greater EAI. Furthermore, emulsification properties showed a significant
difference (p < 0.05) related to the substrate, where FPH from MCF in all cases displayed higher activity
but lower stability compared to HCM. Interestingly, this observation was not expected, as extensive
hydrolysis generally has been associated with decreased emulsifying properties [43]. Larger peptides
are considered more efficient in stabilizing the interface, while small peptides diffuse to and adsorb
faster at the interface, albeit less efficient in interfacial stabilization. Although peptide length is indeed
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a critical factor in O/W emulsification stability [44], peptide sequence and consequently potential
amphiphilicity are of higher importance [8,45]. In addition, variations in charge and thickness of
interfacial layer possess a remarkable impact on the strength and range of the steric and electrostatic
interactions between emulsion droplets, respectively [46].
The observed levels for EAI and ESI are in good agreement with previous studies of FPHs,
where EAI is generally reported to be in the range 25–270 m2/g and ESI in the range 22–48 min [8].
In comparison, hydrolysates from soy and whey protein have been reported to possess EAI in the range
2–12 m2/g and ESI in the range 10–40 min [47]. Consequently, FPHs possess much higher emulsifying
activity without any cost in emulsion stability. In fact, the FPHs produced from cod frame here are
promising for production of highly stable emulsions.
2.3.2. Bulk Foaming Properties
The mechanism of protein/peptide foam formation properties is based on the steady diffusion
of soluble molecules toward the air–water interface with subsequent reorientation and rapid
conformational change at the interface. Thus, the formation of a viscoelastic film around each
gas bubble will enhance the foam stability of the system in a pH-dependent manner [16,48]. In our
study, FC appears to be inversely related to EAI. This also means that increased hydrolysis reduces FC.
As observed for emulsifying properties, higher activity is overall associated with reduced stability.
Neut derived FPHs showed higher FC but lower FS at neutral pH compared to the Alc derived FPHs,
while sequential hydrolysis resulted in the absolute lowest activity, corresponding well with the
protease specificities described already. In general, observed foaming properties are in line with the
previously reported ranges for FPHs, with FC in the range 23–240% and FS in the range 20–140% [8].
In line with our study, Foh et al. [16] also reported that higher DH (MW 0.2–1 KDa) obtained by
application of Alc and Flavorzyme on tilapia fish resulted in lower FC compared to Neut treatments
with lower DH (MW 1–8 KDa), correlating well with other studies of FPHs, where too short peptides
(i.e., too high DH) resulted in decreased foaming properties [49,50]. Although foaming is governed
by interfacial properties, elasticity and intermolecular interactions are of higher importance. As PCL
generally increases interaction strength and hence intra- and inter-peptide elasticity, length of peptides
appears to be of higher importance for foaming than for emulsifying properties [51,52]. Consequently,
amphiphilicity scores predicted in this study cannot be directly correlated to foaming properties.
2.3.3. Interconnection of Bulk Interfacial Properties, Peptide Abundance, and Predicted Emulsifying
Activity
The presence of both hydrophilic and hydrophobic regions in a peptide sequence is a
prerequisite property of emulsifying peptides, as amphiphilicity is crucial to maintaining a stable
O/W interface [53,54]. Facial amphiphilicity is related to peptides with α-helix and β-strand
secondary structures oriented parallel to the O/W interface, whereas γ-peptides are potentially
capable of perpendicular orientation at interface due to their hydrophobic and hydrophilic regions [44],
although γ-peptides are also capable of adopting well defined secondary structures. In this study,
a computational algorithm based on the Kyte–Doolittle hydrophobicity scale was used to predict the
emulsifying properties of the determined peptide sequences, when projected in different possible
conformations. Higher emulsifying scores imply the most probable peptide conformation at the interface
for a given peptide, as this conformation will result in the largest amphiphilic vector. For instance,
emulsifying scores in the order γ > α > β indicates that the peptide has higher amphiphilicity based
on hydrophobic and hydrophilic regions compared to the hydrophilic/hydrophobic faces obtained
when projected in α-helical or β-strand conformation. Emulsifying scores for the 20 most abundant
peptides in each FPH are presented in Table 3, while the predicted emulsifying activity for the 100 most
abundant peptides is found in Table S2. An emulsifying score > 2 means that a peptide is predicted
to be better than 97.5% of all 40,000 random peptides of the same length, used to normalize scores.
Consequently, scores > 2 imply a high probability of being an in vitro emulsifier, and these peptides
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are highlighted in Table 3. Although high emulsifying scores increases the probability of a peptide
being an in vitro functional emulsifier, high scores are implicative and not evidence of functionality,
as demonstrated by Garcia-Moreno et al. [44]. However, it also needs to be noted that in this study that
only peptides in a range of 3–65 AAs were included in the proteomics analysis. Therefore, free AAs,
dipeptides, and undetected peptides in the “grey zone” discussed above, and longer peptides are not
included in the predicting tool, while they are bound to influence the bulk functionality of all FPH
samples. Using a similar approach based on machine learning, Feger et al. [55] recently demonstrated
prediction of cell-penetrating peptide building blocks and subsequent design of axial amphiphilic
peptides capable of producing nanoassemblies for use as a drug delivery system.
The unexpected negative effect of PCL on observed EAI may be explained by the actual
peptide-level composition of the FPHs, when considering the predicted emulsifying properties.
For instance, Neut&Alc treatment resulted in high EAI in both substrates (MCF and HCM). Both FPHs
have several shared peptides with both high abundance and high emulsifying scores. In particular,
two peptides predicted as γ-emulsifiers, IIAPPERKYS (γ = 3.43), and GADPEDVIVA (γ = 3.10)
were highly abundant in both FPHs, constituting 3.49% and 1.43% of the total peptide MS1 intensity
in MCF, while constituting 1.11% and 0.95% in HCM. The significantly higher abundance (3.1-fold
and 1.5-fold, respectively) of both peptides in MCF is likely related to the higher EAI observed for the
FPH from this substrate compared to FPH from HCM. Although the two highly probable γ-emulsifier
peptides are of lower abundance in the HCM Neut&Alc FPH, this FPH contains three additional
peptides with significant abundance (0.53–0.67%) that all have high γ-scores (2.37–2.76), which may
also be partly responsible for the significant EAI observed.
Interestingly, the Alc derived FPH from MCF also displays a very high EAI insignificantly different
from that of Neut&Alc on MCF (p > 0.05). This may be directly related to the presence of a significant
amount (1.16%) of the peptide DIDIRKDLYAN, which is predicted to be a β-emulsifier with a very
high probability (β = 3.65). This peptide, which has the highest predicted score of all top 20 abundant
peptides across all FPHs, is not observed in the top 20 abundant peptides of the Alc derived FPH from
HCM, although identified as the 285th most abundant peptide with a relative abundance of merely
0.06% (Table S3). Both Alc derived FPHs share two predicted γ-emulsifiers (KSYELPDGQVITIG
(γ = 2.64) and ELPDGQVITIG (γ = 2.07)) in significant abundance, which may also contribute to the
bulk emulsifying properties. Although the Alc derived FPH from HCM contains three additional
peptides with scores > 2 in the top 20 most abundant (one α and two γ), it is noteworthy that none of
the top six abundant peptides have scores superseding 1.23 in any conformation. This may also be
directly involved with the significantly lower (p < 0.05) EAI observed compared to Alc derived FPH
from MCF.
Both Neut derived FPHs share three highly abundant and high scoring peptides; two α-emulsifiers
(LEQQVDDLEGSLEQEKK (α = 2.18) and VQHELEEAEERADIAETQVNK (α = 2.21)) and one
γ-emulsifier (IITNWDDMEK (γ = 2.95)), which may contribute to the observed emulsifying activity.
However, as all three peptides are of higher abundance in the FPH from HCM, which in turn has a
significantly lower EAI (p > 0.05), these peptides are likely not the main contributors to the observed
activity. However, the FPH from MCF contain two abundant peptides which are not found in the top 20
abundant peptides in the HCM FPH. The peptide LKGTEDELDKYSEALKDAQEKLE constitutes 0.77%
of the relative MS1 intensity and is predicted to be an α-emulsifier with high probability (α = 2.96),
while the peptide LKGADPEDVIVAA constitutes 0.76% and is predicted to be a γ-emulsifier with high
probability (γ = 2.78).
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Table 3. Sequences, relative intensity (RI), and predicted emulsifying activity (score) in α-helical, β-strand, and γ (axial amphiphilicity) conformation for the 20
peptides with highest relative intensity (PCL > 6) from enzymatically derived FPH from minced cod frame (MCF) and heated cod meat (HCM). Emulsifier prediction
scores > 2 (topmost 2.5%) are highlighted in bold.
MCF
Neut. RI (%)
Emulsifying Scores Alc RI (%) Emulsifying Scores Neut&Alc RI (%) Emulsifying Scores
α β γ α β γ α β γ
LQGEVEDLMVDVERANG 1.94 1.38 −0.45 0.55 GFAGDDAPRAVFPS 2.30 0.29 −0.86 0.71 IIAPPERKYS 3.49 −0.59 −0.62 3.43
LEQQVDDLEGSLEQEKK 1.92 2.18 −0.87 1.26 RVAPEEHPTLL 2.13 0.36 −0.09 1.79 GVDNPGHPF 2.00 1.13 −0.49 0.08
IITNWDDMEK 1.78 0.75 −1.28 2.95 AGDDAPRAVFPS 2.09 0.97 −1.33 1.23 VAPEEHPTL 1.59 −0.18 −0.07 1.04
VQHELEEAEERADIAETQVNK 1.39 2.21 −0.41 0.64 AGPAGPSGPRGPAGIA 1.56 0.16 −0.17 0.47 VLYPPVVEE 1.53 −0.43 −1.16 0.55
LTKLEEAEKAADESERGMK 1.17 1.53 −0.55 1.15 KSYELPDGQVITIG 1.33 −0.78 −0.79 2.64 GADPEDVIVA 1.43 −1.29 −1.00 3.10
LEDQLSEIKAKSDENARQ 1.00 1.54 0.10 1.33 GAAGPAGPSGPRGPAGIA 1.30 0.16 −0.51 0.23 VIDQDKSGFIE 1.35 0.37 −0.43 0.88
LEKSYELPDGQVIT 0.92 −0.55 −0.43 0.82 DIDIRKDLYAN 1.16 −1.24 3.65 0.83 AGDDAPRAVFPS 1.20 0.97 −1.33 1.23
VAPEEHPTL 0.90 −0.18 −0.07 1.04 VAPEEHPTLL 1.12 −0.53 −0.81 1.14 KSYELPDGQ 1.19 −1.09 −0.94 −0.55
IIDQNRDGIISKDDLRD 0.86 −0.51 −0.56 0.70 AGPSGPRGPAGIA 1.08 −0.23 −0.12 1.26 GERGEQGPGGPGGF 1.08 −0.79 −0.73 1.36
LDDLQAEEDKVNT 0.81 0.55 −1.02 1.17 NWDDMEKIWHH 1.06 0.75 −0.27 1.02 IIDQNRDGIIS 0.83 0.68 −0.86 1.67
LEKTIDDLEDELYAQK 0.78 1.51 −0.63 0.12 GQKDSYVGDEAQSKRGILTL 0.92 −0.71 −0.30 1.27 AGPAGPSGPRGPAG 0.81 −0.56 −0.48 0.21
LKGTEDELDKYSEALKDAQEKLE 0.77 2.96 0.22 0.47 LRVAPEEHPTL 0.88 0.64 1.15 1.24 GLPGPSGPSGPRGR 0.78 −0.81 −1.11 0.80
LTEEMASQDESVAK 0.76 1.01 −0.17 0.11 RGDSGPAGPPGEQGML 0.84 −1.16 −0.62 0.13 RGEQGPGGPGGF 0.76 −1.42 −0.18 1.04
LKGADPEDVIVAA 0.76 −1.53 −0.19 2.78 ELPDGQVITIG 0.82 −0.99 0.01 2.07 GFAGDDAPRA 0.69 0.45 −0.67 1.06
LADWKQKYEEGQAELEGSLKEARS 0.71 0.70 −0.08 0.43 SGSAGKDGMSGLPGPSGPSGPRGR 0.67 −0.23 −1.12 0.32 AINDPFIDL 0.67 0.83 −0.47 0.47
SKYETDAIQRTEELEESKKK 0.69 0.71 −0.69 1.57 LLPVLYPPVVEE 0.67 0.24 −1.23 1.33 KAGDSDGDGAIGVD 0.59 −0.30 0.65 1.81
LKAGDSDGDGAIGVDEWAV 0.69 0.26 −0.72 1.09 SGPGGPTGPSGM 0.64 −1.24 −0.74 −0.49 GFAGDDAPRAVFPS 0.58 0.29 −0.86 0.71
LTDAETKAF 0.65 0.43 −0.14 −0.44 KSYELPDGQVITIGNE 0.62 −0.17 −0.82 1.35 LEDQLSELK 0.54 1.36 −1.20 −0.22
LKAGDSDGDGAIGVDEWAVLVKA 0.61 −0.98 −1.16 1.53 GPAGPSGPRGPAGIA 0.59 −0.10 −0.37 0.91 KILDPEAT 0.52 0.59 −0.71 0.96
VDDIIQTGVDNPGHPFIMT 0.59 0.89 0.34 0.07 FAGDDAPRAVFPS 0.58 0.35 −0.89 0.70 GKDGMSGLPGPSGPSGPRGR 0.52 −0.08 −0.72 0.47
HCM
Neut. RI (%) α β γ Alc RI (%) α β γ Neut&Alc RI (%) α β γ
LEQQVDDLEGSLEQEKK 2.38 2.18 −0.87 1.26 AGDDAPRAVFPS 3.13 0.97 −1.33 1.23 VAPEEHPTL 1.91 −0.18 −0.07 1.04
LQGEVEDLMVDVERANG 2.28 1.38 −0.45 0.55 GPAGPSGPRGPAGIA 2.64 −0.10 −0.37 0.91 VLYPPVVEE 1.75 −0.43 −1.16 0.55
IITNWDDMEK 2.23 0.75 −1.28 2.95 AGPAGPSGPRGPAGIA 1.90 0.16 −0.17 0.47 IIDQNRDGIIS 1.45 0.68 −0.86 1.67
VQHELEEAEERADIAETQVNK 1.46 2.21 −0.41 0.64 VAPEEHPTLL 1.87 −0.53 −0.81 1.14 ELPDGQVIT 1.14 −1.76 −0.72 1.69
LEKSYELPDGQVIT 1.27 −0.55 −0.43 0.82 GFAGDDAPRAVFPS 1.75 0.29 −0.86 0.71 VIDQDKSGFIE 1.13 0.37 −0.43 0.88
VETEKTEIQSALEEAEGTLEHEESKILR 1.00 2.29 −0.80 0.25 GAAGPAGPSGPRGPAGIA 1.62 0.16 −0.51 0.23 IIAPPERKYS 1.11 −0.59 −0.62 3.43
LDDLQAEEDKVNT 0.94 0.55 −1.02 1.17 RVAPEEHPTLL 1.53 0.36 −0.09 1.79 LEDQLSELK 1.06 1.36 −1.20 −0.22
LADWKQKYEEGQAELEGSLKEARS 0.74 0.70 −0.08 0.43 ELPDGQVITIG 1.34 −0.99 0.01 2.07 GVDNPGHPF 1.00 1.13 −0.49 0.08
VAPEEHPTL 0.72 -0.18 −0.07 1.04 KSYELPDGQVITIG 1.21 −0.78 −0.79 2.64 GADPEDVIVA 0.95 −1.29 −1.00 3.10
LDDVIQTGVDNPGHPFIMT 0.71 0.83 0.33 −0.02 LLPVLYPPVVEE 1.09 0.24 −1.23 1.33 AAGPAGPSGPRGPAG 0.75 −0.56 −0.75 0.55
LEDECSELKKDIDDLELT 0.71 1.84 −0.42 0.82 LGEQIDNL 1.03 2.57 −0.40 −0.40 AGDDAPRAVFPS 0.71 0.97 −1.33 1.23
ARIEELEEELEAERA 0.68 −0.65 −0.93 0.54 RGDSGPAGPPGEQGML 0.94 −1.16 −0.62 0.13 LDKNKDPLNDSVVQ 0.68 1.41 −0.79 1.18
LTEEMASQDESVAK 0.67 1.01 −0.17 0.11 GSAGPRGPSGNIGMPGMTGPQ 0.85 −1.75 −0.73 0.14 FAGDDAPRA 0.67 0.49 −0.69 1.15
IEELEEELEAERA 0.65 0.22 0.05 1.05 TIIDQNRDGIIS 0.76 0.70 −0.99 1.49 ELPDGQVITI 0.67 −0.93 0.00 2.37
LDFENEMAT 0.65 0.10 1.04 0.59 GEKLKGADPEDVIVA 0.74 −1.01 −0.41 2.36 KSYELPDGQVITIG 0.63 −0.78 −0.79 2.64
VDDIIQTGVDNPGHPFIMT 0.63 0.89 0.34 0.07 SGSAGKDGMSGLPGPSGPSGPRGR 0.67 −0.23 −1.12 0.32 GFNPPDLDIM 0.60 −0.75 −0.19 1.20
LKAGDSDGDGAIGVDEWA 0.61 0.26 −0.18 0.56 SGPGGPTGPSGM 0.67 −1.24 −0.74 −0.49 ELPDGQVI 0.60 −1.92 −0.85 0.68
LVQVQGEVDDSVQEARNAEEKAKKA 0.60 2.64 1.54 2.42 GEQIDNL 0.67 1.96 −1.14 0.44 NPPKYDKIEDM 0.55 −0.15 −0.70 1.79
ALEEAEGTLEHEESKLLR 0.58 1.83 −0.16 0.57 ELPDGQVI 0.66 −1.92 −0.85 0.68 KSYELPDGQVITI 0.53 −0.70 −0.82 2.76
IEELEEELEAERAAR 0.56 −0.70 0.82 0.31 KSYELPDGQVITI 0.65 −0.70 −0.82 2.76 KSYELPDGQVIT 0.51 −1.28 −1.17 1.13
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As shown here, PCL may in many cases be a good indicator of emulsifying potential, but the
specific sequence and the resulting structural aspects of interfacial conformation appear more important.
In line with this, previous studies have shown that physical stability of fish oil emulsion is indeed
influenced by PCL in an interfacial conformation dependent manner, as α-helical peptide emulsifiers
were generally better when the PCL was in the range 18–29 AAs, while β-emulsifiers appeared to
be best in the range 13–15 AAs [44]. This is in line with the PCL of the peptides identified here
predicted as emulsifiers in the different conformations. Nevertheless, emulsifying activity of protein
hydrolysates is a complex mechanism, as the mixture of peptides and their abundance is highly complex.
This also means that it may not be straightforward to directly transfer knowledge from isolated peptide
emulsifiers to hydrolysates, as the nature of the functionality is influenced by cooperative, cumulative,
and inhibitory effects in the interplay between individual peptides [56]. This further implies that there
may indeed also be peptides not found in the top 20 most abundant, which greatly influence the bulk
properties. For instance, in the top 100 most abundant (Table S2), there are several peptides with very
high scores (>3), which may influence the FPH properties and hence interesting leads to investigate in
further detail.
Although we previously argued that amphiphilicity scores cannot be directly correlated to
foaming properties, there are several interesting peptide-level observations that may explain bulk
foaming properties to some degree. In addition to the apparent PCL-dependency, Neut derived
FPHs, which show the highest FC, contain several peptides with predicted α-helical amphiphilicity,
and although they may not be the key peptides in the observed O/W emulsifying properties, they may
very well be able to form a peptide film at the air/water interface. As secondary structure is a
prerequisite for strong intermolecular interactions through self-assembly [57,58], the significantly
larger proportion of peptides predicted to have a potentially amphiphilic, well-defined secondary
structure at the interface may also explain why significantly higher FC is observed for single enzyme
treatments compared to sequential hydrolysis. The lower stability of Neut derived FPH from HCM
compared to MCF may therefore also be related to the lower EAI observed. Similarly, the higher FC
and FS observed for Alc derived FPH from MCF compared to HCM may to a degree be ascribed to the
presence of the high scoring β-emulsifier, as particularly β-strand peptides are associated with higher
elasticity of interfacial layers/films [58,59].
2.4. Antioxidative Properties
2.4.1. Bulk Antioxdiative Properties
The antioxidative activity of FPHs from both MCF and HCM, evaluated by DPPH radical
scavenging activity (RSA) and chelating capacity of ferrous iron (MCA), is presented in Table 1.
While RSA describes the ability to transfer an electron to a radical oxidant, MCA describes the ability to
chelate metals and thereby potentially prevent the catalytic breakdown of lipid peroxides, which leads
to the formation of reactive alkoxyl radicals and volatile oxidation products responsible for off-flavor
formation [60]. DPPH RSA of all FPHs exhibited significantly different concentrations for obtaining
50% inhibition (IC50; p < 0.05). All FPHs from HCM showed higher DPPH RSA compared to FPHs
from MCF, and the highest effectiveness was observed for HCM obtained by sequential application
of Neut&Alc (IC50 = 2.9 mg/mL). In contrast, FPHs from MCF showed higher MCA compared to
FPHs from HCM (p < 0.05). Previous studies of the antioxidative properties of cod frame FPHs are
somewhat inconclusive in terms of the influence of DH [5,61], but, generally, antioxidant activity is
higher for lower MW fractions. Those findings correspond well with previous studies indicating that
antioxidant activity in hydrolysates is positively correlated with the increase of DH [16,62], and high
antioxidant activity is usually seen for peptides spanning 5–16 AAs [8,50,63], i.e., the shorter peptides,
the higher antioxidative activity. Foh et al. [16] attributed that higher functionality and bioactivity of
Alc derived peptides to the peptides fraction with MW < 1 KDa, compared to FPH from Neut and
Flavourzyme that was characterized by a high percentage of peptides with MW ranging from 8 kDa to
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15 kDa. Nevertheless, our data do not suggest a general correlation between increased hydrolysis and
increased antioxidant activity, although several studies have found antioxidative peptides to be rather
short and usually in the range 5–16 AAs [8,50,63,64]. However, the highest DPPH RSA was found for
the FPHs obtained by sequential hydrolysis (i.e., highest DH and lowest PCL) for both MCF and HCM
compared to other treatments on the same substrate [65]. There does not appear to be any apparent
correlation with the mean peptide charge, Pzavg (Table 2) for neither RSA nor MCA.
As discussed for emulsifying activity, considering hydrolysis and PCL alone as a determining
factor for antioxidant activity is naive. Studies have shown that changes in concentration and
composition of the free amino acids [66] and small peptides [67] influence the antioxidative activity of
protein hydrolysates [68]. Furthermore, the presence of specific amino acids and their distribution and
special orientation contribute to the overall antioxidative activity. This covers inclusion of aromatic
AAs such as Tyr, Trp, and Phe [47,69,70], hydrophobic AAs including Val, Leu, and Ala [47,69–72]
sulphur-containing AAs, i.e., Met and Cys [47,69,70], acidic AAs, i.e., Glu and Asp [71,73], alkaline AAs,
i.e., His, Lys and Arg [47,70,74,75], as well as Pro [8], which all may dramatically influence the
antioxidative activity of peptides. Furthermore, high content of N-terminal Leu, Ala and Val has also
been reported to positively affect antioxidant activity [8,76]. This means that it is highly problematic to
make any generalized assumptions regarding AA composition in antioxidative peptides, as this is of a
highly complex nature.
2.4.2. Interconnection of Bulk Antioxidative Properties, Peptide Abundance, and Predicted
Antioxidative Activity
In order to obtain a better understanding of the underlying principles for peptide antioxidative
activity, computational approaches are needed. For this specific application, AnOxPePred, a neural
network algorithm for prediction of antioxidant activity, has been developed using verified antioxidative
peptides as input for feature and pattern recognition [77]. Predicted free radical scavenging (FRS)
and metal chelating activity (MCA) for the 20 most abundant peptides from each FPH are presented in
Table 4, while the scores for the 100 most abundant peptides from each FPH are presented in Table
S4. The lowest in vitro DPPH RSA (i.e., highest IC50) was for both substrates determined in the
Alc derived FPH. Surprisingly, the Alc derived FPH for both substrates show the highest number
(and cumulative abundance) of peptides predicted to display RSA (i.e., scores > 0.43) [77]. Furthermore,
the highest scoring peptide of all, LLPVLYPPVVEE (FRS = 0.64), was found in both Alc derived FPHs.
Nevertheless, when comparing the abundance of the peptide, it is significantly more abundant in
the FPH from HCM (1.09% vs. 0.65%, i.e., 1.7-fold). This is also observed for another high scoring
(FRS = 0.56) peptide VAPEEHPTLL (1.87% vs. 1.12%, i.e., 1.7-fold), which may explain the higher
DPPH RSA observed for the Alc derived FPH from HCM compared to the FPH from MCF. The peptide
SGSAGKDGMSGLPGPSGPSGPRGR was also predicted to be a FRS with a high score (FRS = 0.55)
but was present in equivalent abundance in both FPHs (0.67%). A number of other peptides with
predicted RSA above the score threshold (FRS = 0.43–0.51) was also found in both FPHs, but their
relative abundance varied between samples, thereby making it difficult to assess their influence on the
bulk RSA.
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Table 4. Sequences, relative intensity (RI), and predicted free radical scavenging (FRS) and metal chelating activity (MCA) scores for the 20 peptides with highest
relative intensity from enzymatically derived FPH from minced cod frame (MCF) and heated cod meat (HCM). DPPH scores >0.43 and MCA scores >0.3 are
highlighted in bold providing the best cutoff between positive and negative predictions according to the models [77].
MCF
Neut. Rel. Int. (%)
Score Alc Rel. Int. (%) Score Neut&Alc Rel. Int. (%) Score
FRS MCA FRS MCA FRS MCA
LQGEVEDLMVDVERANG 1.94 0.33 0.17 GFAGDDAPRAVFPS 2.30 0.51 0.25 IIAPPERKYS 3.49 0.40 0.23
LEQQVDDLEGSLEQEKK 1.92 0.38 0.19 RVAPEEHPTLL 2.13 0.51 0.26 GVDNPGHPF 2.00 0.56 0.28
IITNWDDMEK 1.78 0.38 0.19 AGDDAPRAVFPS 2.09 0.41 0.24 LDLL 1.75 0.35 0.28
LTKLEEAEKAADESERGMK 1.17 0.29 0.17 AGPAGPSGPRGPAGIA 1.56 0.51 0.21 VGPF 1.65 0.47 0.27
LEDQLSEIKAKSDENARQ 1.00 0.23 0.17 FLGM 1.34 0.43 0.28 VAPEEHPTL 1.59 0.51 0.25
LEKSYELPDGQVIT 0.92 0.48 0.23 KSYELPDGQVITIG 1.33 0.35 0.21 VLYPPVVEE 1.53 0.52 0.21
VAPEEHPTL 0.90 0.51 0.25 GAAGPAGPSGPRGPAGIA 1.30 0.49 0.20 GADPEDVIVA 1.43 0.32 0.20
IIDQNRDGIISKDDLRD 0.86 0.30 0.22 DIDIRKDLYAN 1.16 0.27 0.17 VIDQDKSGFIE 1.35 0.30 0.19
LDDLQAEEDKVNT 0.81 0.34 0.23 VAPEEHPTLL 1.12 0.56 0.26 AGDDAPRAVFPS 1.20 0.41 0.24
LEKTIDDLEDELYAQK 0.78 0.35 0.22 AGPSGPRGPAGIA 1.08 0.47 0.20 KSYELPDGQ 1.19 0.44 0.23
LKGTEDELDKYSEALKDAQEKLE 0.77 0.34 0.16 NWDDMEKIWHH 1.06 0.34 0.20 VAVL 1.17 0.33 0.23
LTEEMASQDESVAK 0.76 0.31 0.21 GQKDSYVGDEAQSKRGILTL 0.92 0.30 0.18 LFPE 1.17 0.44 0.30
LKGADPEDVIVAA 0.76 0.38 0.19 NWDDME 0.88 0.40 0.21 GLVL 1.16 0.37 0.24
LADWKQKYEEGQAELEGSLKEARS 0.71 0.30 0.15 LRVAPEEHPTL 0.85 0.45 0.25 LLEM 1.12 0.39 0.27
SKYETDAIQRTEELEESKKK 0.69 0.40 0.14 RGDSGPAGPPGEQGML 0.84 0.51 0.29 GERGEQGPGGPGGF 1.08 0.52 0.23
LKAGDSDGDGAIGVDEWAV 0.69 0.35 0.18 ELPDGQVITIG 0.74 0.31 0.20 LGVL 0.95 0.38 0.25
LTDAETKAF 0.65 0.33 0.24 SGSAGKDGMSGLPGPSGPSGPRGR 0.67 0.55 0.25 LDFENE 0.87 0.37 0.27
LKAGDSDGDGAIGVDEWAVLVKA 0.61 0.36 0.13 LDLL 0.67 0.35 0.28 IIDQNRDGIIS 0.83 0.29 0.19
VDDIIQTGVDNPGHPFIMT 0.59 0.42 0.20 LLPVLYPPVVEE 0.65 0.64 0.21 AGPAGPSGPRGPAG 0.81 0.49 0.22
VIDQDKSGFIEEDELKLF 0.57 0.36 0.19 SGPGGPTGPSGM 0.64 0.50 0.23 LLLS 0.79 0.34 0.29
HCM
Neut. Rel. Int. (%) FRS MCA Alc. Rel. Int. (%) FRS MCA Netu&Alc Rel. Int. (%) FRS MCA
LEQQVDDLEGSLEQEKK 2.38 0.38 0.19 AGDDAPRAVFPS 3.13 0.41 0.24 VAPEEHPTL 1.91 0.51 0.25
LQGEVEDLMVDVERANG 2.28 0.33 0.17 GPAGPSGPRGPAGIA 2.64 0.49 0.21 VLYPPVVEE 1.75 0.52 0.21
IITNWDDMEK 2.23 0.38 0.19 AGPAGPSGPRGPAGIA 1.90 0.51 0.21 IIDQNRDGIIS 1.45 0.29 0.19
VQHELEEAEERADIAETQVNK 1.46 0.33 0.15 VAPEEHPTLL 1.87 0.56 0.26 ELPDGQVIT 1.14 0.36 0.23
LEKSYELPDGQVIT 1.27 0.48 0.23 GFAGDDAPRAVFPS 1.75 0.51 0.25 VIDQDKSGFIE 1.13 0.30 0.19
VETEKTEIQSALEEAEGTLEHEESKILR 1.00 0.37 0.13 GAAGPAGPSGPRGPAGIA 1.62 0.49 0.20 IIAPPERKYS 1.11 0.40 0.23
LDDLQAEEDKVNT 0.94 0.34 0.23 FLGM 1.53 0.43 0.28 FLPM 1.07 0.46 0.31
LADWKQKYEEGQAELEGSLKEARS 0.74 0.30 0.15 RVAPEEHPTLL 1.42 0.51 0.26 LEDQLSELK 1.06 0.34 0.25
VAPEEHPTL 0.72 0.51 0.25 ELPDGQVITIG 1.34 0.31 0.20 GVDNPGHPF 1.00 0.56 0.28
LFQPSF 0.72 0.42 0.28 KSYELPDGQVITIG 1.21 0.35 0.21 GADPEDVIVA 0.95 0.32 0.20
LDDVIQTGVDNPGHPFIMT 0.71 0.41 0.21 LLPVLYPPVVEE 1.09 0.64 0.21 AAGPAGPSGPRGPAG 0.75 0.49 0.22
LEDECSELKKDIDDLELT 0.71 0.26 0.18 LGEQIDNL 1.03 0.35 0.22 AGDDAPRAVFPS 0.71 0.41 0.24
ARIEELEEELEAERA 0.68 0.36 0.20 NWDDME 0.94 0.40 0.21 LDKNKDPLNDSVVQ 0.68 0.29 0.27
LTEEMASQDESVAK 0.67 0.31 0.21 RGDSGPAGPPGEQGML 0.90 0.51 0.29 FAGDDAPRA 0.67 0.37 0.22
FLPM 0.66 0.46 0.31 FETF 0.85 0.40 0.25 ELPDGQVITI 0.67 0.33 0.20
IEELEEELEAERA 0.65 0.36 0.20 GSAGPRGPSGNIGMPGMTGPQ 0.84 0.48 0.23 KSYELPDGQVITIG 0.63 0.35 0.21
LDFENEMAT 0.65 0.37 0.25 TIIDQNRDGIIS 0.76 0.29 0.20 LDFENE 0.60 0.37 0.27
VDDIIQTGVDNPGHPFIMT 0.63 0.42 0.20 GEKLKGADPEDVIVA 0.70 0.38 0.17 GFNPPDLDIM 0.60 0.39 0.25
LKAGDSDGDGAIGVDEWA 0.61 0.35 0.19 SGSAGKDGMSGLPGPSGPSGPRGR 0.67 0.55 0.25 ELPDGQVI 0.60 0.36 0.25
LVQVQGEVDDSVQEARNAEEKAKKA 0.60 0.34 0.11 SGPGGPTGPSGM 0.67 0.50 0.23 LDLL 0.58 0.35 0.28
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For both MCF and HCM, the FPH obtained by sequential hydrolysis was observed to display the
highest RSA, when comparing between treatments, with the FPH from HCM showing the highest
activity. This is surprising, as the highest scoring peptide from Neut&Alc FPHs, i.e., GVDNPGHPF,
is two-fold more abundant in the MCF FPH (2.0% vs. 1.0%). Consequently, this peptide cannot explain
the difference observed. In contrast, two other peptides with FRS scores above the threshold are more
abundant in the HCM FPH, VAPEEHPTL (FRS = 0.51–1.91% vs 1.59%), VLYPPVVEE (FRS = 0.52–1.75%
vs. 1.53%), and may be involved in the higher activity observed. Furthermore, the tetrapeptide FLPM
(FRS = 0.46) is not observed in the top 20 abundant peptides of the MCF FPH (RI = 0.08%, Table S3)
but is highly abundant (1.1%) in the HCM FPH, which also makes this a highly interesting peptide,
in terms of describing the observed differences. FLPM is also observed in the Neut derived FPH from
HCM but with lower abundance (0.66%). This may also be a part of the lower DPPH RSA observed for
this FPH compared to the sequential FPH from HCM, but also the higher DPPH RSA compared to
the Neut derived FPH from MCF, where the peptide is not observed in significant abundance (0.04%,
Table S3).
In terms of MCA, only one peptide with a score over the threshold (MCA > 0.3) was observed in
the top 20 abundant peptides across all samples. The peptide, FLPM (MCA = 0.31), was also predicted
to be a potential FRS as discussed above. Nevertheless, the peptide was identified with the highest
abundance in the sequential hydrolysate from HCM, which was in fact the FPH with the lowest
MCA of all six FPHs. Consequently, there are likely other significantly different factors describing
the observed differences than predicted by AnOxPePred. For metal chelation, secondary and tertiary
structure may be a very important factor, as for instance metalloenzymes, which coordinate cationic
species, usually have highly complex and well-defined coordination sites, which are highly influenced
by structural changes [78,79].
When comparing between substrates, the FPH obtained from HCM did in all cases display the
highest RSA, whereas the FPHs from MCF displayed the highest MCA, indicating the substrate used
for hydrolysis is of importance. For instance, FPHs from HCM contain a significantly higher amount
of calcium [2]. As calcium is a divalent cation similar to Fe2+, a higher content may explain why
we observe a generally lower MCA for FPHs obtained from HCM. Bones also contain a significant
amount of free radicals or reactive oxygen species (ROS) produced by osteoclasts [80,81] as part of
bone metabolism and signaling. As MCF includes cut bones during hydrolysis, they may be the source
of ROS, which in turn will impair the RSA of the hydrolysates, as the FPH already contains ROS and/or
FRS peptides may have already donated an electron to endogenous ROS. This could be the underlying
reason of FPHs from MCF generally displaying lower RSA. Consequently, it could be argued that,
due to these factors, FPHs from the different substrates may be hard to compare directly in terms of
in vitro antioxidant activity.
When predicting peptide functionality and bioactivity using computational methods, it is of
great importance to consider and differentiate between background and function of an algorithm.
EmulsiPred calculates an amphiphilicity vector based on the AA distribution in a given conformation.
This means that it models the peptide and then determines a physio-chemical property, which is
independent of a training dataset and can be regarded as a global, sequence-dependent constant
attribute. In contrast, AnOxPePred uses a neural network that has been trained on experimental data,
and consequently relies heavily on the size and the quality of the dataset. As limited, high-quality data
for this, in particularly true negatives, exist, the model performance may be suboptimal [77]. This is
especially the case for MCA prediction, where the training dataset is very limited. These observations
may also explain why prediction of emulsifying activity appears to describe the unexpected trends
(in terms of DH-dependency) quite well, while the predictions for both RSA and MCA appear to be
somewhat lacking in describing the observed differences. Limitations in the prediction model may also
explain why high scoring peptides appear to adhere well to the overall characteristics for antioxidant
peptides outlined above. Furthermore, as mentioned for emulsifying peptides, there may very well
be peptides not included in the top 20 abundant that influence the bulk properties. Indeed, there are
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several peptides in the top 100 (Table S4) which have very high FRS (>0.6) as well as peptides with
significant MCA (>0.3), which may contribute to the observed bulk properties. Nevertheless, this study
has identified a large number of promising peptides with predicted functionality, which allow for
further investigation of peptide-level functionality.
3. Materials and Methods
Cod frames were received from Espersen Company, (Espersen A/S, LT 94102, Klaipeda, Lithuania)
in a batch of 7 kg (September 2017) in frozen condition stored at −40 ◦C until hydrolysis. Alcalase®
2.4 L FG (Alc; declared activity of 2.4 AU/g) and Neutrase® 0.8 L (Neut; declared activity 0.8 AU/g)
was provided by Novozymes Company (Novozymes A/S, 2880, Bagsværd, Denmark). Sodium caseinate
(MIPRODAN 30) was provided by Arla Company (Arla Foods Ingredients amba, Viby J, Denmark).
All chemical reagents used for experiments were of analytical grade.
3.1. Enzymatic Hydrolysis Procedure
The enzymatic hydrolysis carried out as described in Jafarpour et al. [2]. Briefly, cod frames were
cut into smaller parts and then divided in two batches; minced cod frame (MCF) and heated cod meat
(HCM) were boiled for 20 min at 95 ◦C, and the bones were subsequently removed. Alc and Neut
enzymes were applied either individually (3 h) or sequentially (2 × 3 h) and proteolysis was performed
at 50 ◦C, pH 7.4, using an enzyme/substrate ratio of 1.5%.
Degree of Hydrolysis (DH)
DH was estimated from α-amino nitrogen following Nielsen et al. [28];
DH% =
αANhyd
αANtot
× 100% (1)
where αANhyd is the α-amino-N content of the hydrolysates (mM/g) and αANtot is the α amino-N
content of the fully hydrolyzed substrate (mM/g). αANtot was calculated based on the HPLC-MS total
amino acid analysis and protein content of the untreated substrate previously reported [2]. The αANhyd
was determined using the PractiChromTM PFAN-25 free amino nitrogen assay kit (BioAssay Systems,
Hayward, CA, USA) by application of Picoexplorer™ apparatus (model PAS-110, USHIO, Cypress,
CA, USA). Accordingly, the ninhydrin-based reaction was performed by adding of 150 µL of reagent
in 5 µL of dissolved FPH, and incubating for 10 min at 100 ◦C. Thereafter, the reaction mixture was
cooled to room temperature by leaving on bench for 15 min. Absorbance was measured at 530 nm and
standard curve was obtained using glycine (BioAssay Systems, Hayward, CA, USA) as free α-amino
group. Based on the determined DH for each FPH, the average peptide chain length (PCL) for the
hydrolysate was calculated according to [22], as:
PCL =
1
DH (%)
(2)
3.2. Emulsifying Properties
The emulsifying activity index (EAI) and the emulsion stability index (ESI) were determined
using the method described by [17,82] with slight modification. Accordingly, 15 mL portions of
2 mg/mL protein solution of each hydrolysate sample were mixed with 5 mL rapeseed oil using an
ultraturax homogenizer (IKA, Staufen, Germany) at a speed of 9500 rpm for 60 s without pH adjustment.
Afterward, aliquots of 50 µL were pipetted from the bottom of the container at 0 and 10 min after
homogenization and then mixed with 5 mL of 0.1% sodium dodecyl sulfate (SDS) (Sigma-Aldrich,
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St. Louis, MO, USA) solution in order to measure the absorbance of the diluted solution at 500 nm
using a spectrophotometer (Shimadzu, UV-1280, Kyoto, Japan). EAI was calculated as:
EAI(
m2
g
) =
2× 2.303×A0 ×D
∅× c× 10000 (3)
where A0 is the absorbance immediately following homogenization, D is the dilution factor, ∅ is the oil
volume fraction, and c is protein concentration (g/mL).
ESI was calculated as:
ESI(min) =
(
A0
A0 −A10
)
× 10 min (4)
where A0 is the absorbance immediately following homogenization and A10 is the absorbance at 10 min.
Sodium caseinate (2 mg/mL) protein solution was used as control. Measurements were performed
in triplicates.
3.3. Foaming Properties
Foaming capacity (FC) and foaming stability (FS) were determined according to the method
of [83]. Accordingly, 25 mg of each protein hydrolysate sample were dissolved in 25 mL of distilled
water solution (0.1 % w/v) and mixed by a magnet stirrer for 3 min and then homogenized at 9500 rpm
for 120 s using an Ultraturrax (IKA, Staufen, Germany), and finally poured into a 200 mL graduated
cylinder. FC was determined by recording the foam volume immediately after homogenization and
calculated as:
FC(%) =
V0f oam
Vinit
× 100% (5)
where V0f oam is the foam volume immediately after homogenization and Vinit is the initial sample
volume before homogenization.
FS is calculated after a 30 min resting period as:
FS(%) =
V30f oam
V0f oam
× 100% (6)
where V30f oam is the foam volume after 30 min and V
0
f oam is the foam volume immediately
after homogenization.
3.4. In Vitro Antioxidant Properties
3.4.1. Diphenyl-1-Picryhhydrazyl (DPPH) Radical Scavenging Activity (RSA)
Solutions of FPH at different concentrations were added to an equal volume of 0.1mM DPPH
(Sigma-Aldrich, St. Louis, MO, USA) in 96% EtOH (Sigma-Aldrich, St. Louis, MO, USA) in a microplate
(Eon 2, BioTek, Winooski, VT, USA). A blank of each sample (sample + EtOH) was included as a
negative control. Three blind samples (EtOH + DPPH) were also prepared on the plate. The plate was
incubated for 30 min at room temperature in darkness before measuring the absorbance at 517 nm
using a microplate reader (Eon 2, BioTek, Winooski, VT, USA). Scavenging activity was calculated as
inhibition percentage (IRS) using mean absorbance as:
IRS(%) = (1−
As −A0
Ab
) × 100% (7)
where As is the absorbance of DPPH after reaction with antioxidant, A0 is the absorbance of antioxidant
and EtOH negative control), and Ab is the absorbance of EtOH and DPPH (blind).
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Based on the inhibition percentages for the different concentration for each FPHs, RSA was
determined as the IC50 based on linear regression. Each sample concentration was measured
in triplicate.
3.4.2. Metal Chelating Activity (MCA)
In addition, 100 µL of solution of each FPH at different concentrations was added to a microplate
(Eon 2, BioTek, Winooski, VT, USA). Furthermore, 0.5 mM EDTA (Sigma-Aldrich, St. Louis,
MO, USA) was used as positive control. To start the reaction, 20 µL of 0.5 mM ferrous chloride
(Sigma-Aldrich, St. Louis, MO, USA) was added to the plate and mixed in a plate mixer for 3 min at
300–600 rpm. Subsequently, 20 µL of 2.5 mM ferrozine (Sigma-Aldrich, St. Louis, MO, USA) was added.
Blanks consisted of only iron chloride and Ferrozin. The plate was mixed and left for 10 min in dark at
room temperature. The absorbance at 562 nm was measured using a microtiterplate-reader (Eon 2,
BioTek, Winooski, VT, USA). Ferrous chelating activity (FCA) was calculated as inhibition percentage
(IFCA) using mean absorbance as:
IFCA(%) = (
Ablank −
(
Asample −Ablind
)
Ablank
) × 100% (8)
where Ablank is the absorbance of blank, Asample is the absorbance of sample, and Ablind is the absorbance
of blind (only FPH).
Based on the inhibition percentages for the different concentration for each FPHs, the MCA
was determined as the EC50 based on linear regression. Each sample concentration was measured
in triplicate.
3.5. 1D SDS-PAGE Analysis
Freeze-dried FPH samples were solubilized with 2% SDS (AppliChem GmbH, Darmstadt,
Germany) in 200 mM ammonium bicarbonate (Sigma-Aldrich Chemie GmbH, Steinheim, Germant)
(pH 9.5) to a final protein/peptide concentration of 2 mg/mL based on determined protein content
by Dumas, as previously described [2]. Samples were vortexed for 2 min and sonicated for 30 min.
Subsequently, samples were centrifuged at 4000× g for 15 min to precipitate insoluble proteins/peptides
and solids using a 5810 R centrifuge (Eppendorf, Hamburg, Germany). SDS-PAGE analysis was
performed using precast Criterion 16.5% Tris-Tricine gels (Bio-Rad, Hercules, CA, USA) under reducing
conditions according to manufacturer guidelines by loading 20 µg protein/peptide in Tricine sample
buffer (Bio-Rad) containing dithiothreitol (Roche Diagnostics GmbH, Mannheim, Germany) to a
final concentration of 50 mM (denatured at 95 ◦C for 5 min). As molecular weight (MW) marker,
Unstained Polypeptide SDS-PAGE Standard P/N 1610326 (Bio-Rad) was used. To alleviate low signal
intensity and smearing, an identical gel was prepared but loading 10-fold more protein/peptide in
each well. For full range visualization, SDS-PAGE analysis was also performed on precast 4–20%
gradient gels (GenScript, Piscataway, NJ, USA) in a Tris-MOPS buffered system under the same general
conditions as above using both 20 µg and 200 µg protein/peptide per well. As the MW marker, PIERCE
Unstained Protein MW Marker P/N 26610 (ThermoFisher Scientific, Rockford, IL, USA) was used.
Protein/peptide visualization was achieved with Coomassie Brilliant Blue G250 (Sigma-Aldrich Chemie
GmbH) staining using a ChemDoc MP Imaging System (Bio-Rad).
3.6. Reference Proteome Construction
The reference sequence database for peptide identification was derived from two existing
assemblies: GadMor_May2010 [84] and ASM90030256v1 [85], as previously described [2]. The proteome
contained 74913 protein entries with an average length of 325.7 amino acids (AAs), calculated using
the Sequence Length FASTA Tool [86].
Mar. Drugs 2020, 18, 599 19 of 26
3.7. LC-MS/MS and Proteomics Data Analysis
FPH samples were analyzed as previously reported [2]. In short, hydrolysates were reduced
and alkylated in-solution before desalting using C-18 StageTips. Analysis was performed using an
EASY-nLC system (Thermo Scientific, Bremen, Germany) online coupled to a Q Exactive HF mass
spectrometer (Thermo Scientific) following separation on a RP Acclaim Pepmap RSLC analytical
column (C18, 100 Å, 75 µm. × 50 cm, nanoViper fittings (Thermo Scientific).
Data analysis was performed as previously described using MaxQuant 1.6.0.16 [36,37] with the
constructed reference proteome. The analysis was performed using unspecific digestion and a defined
peptide length of 3 to 65 AAs. A false discovery rate of 1% was applied on both the peptide and
protein level.
3.7.1. Post-Processing of Proteomics Data
Building on the principles of intensity-weighed peptide abundance estimation previously
outlined [2], we defined a number of parameters for sample characterization and comparison.
These parameters relate to the average peptide chain length (PCLavg), average peptide molecular
weight (PMWavg), and average peptide charge (Pzavg) at physiological conditions (pH 7) determined
as weighted means according to:
PCLavg =
∑n
p=1 PCLp ∗ Ip∑n
p=1 Ip
(9)
PMWavg =
∑n
p=1 PMWp ∗ Ip∑n
p=1 Ip
(10)
Pzavg =
∑n
p=1 Pzp ∗ Ip∑n
p=1 Ip
(11)
where PCLp, PMWp, and Pzp is the length, MW, and charge at pH 7 for a given peptide p of all n peptides
identified in a sample and Ip is the intensity of peptide p (the weight). For comparison, unweighted
averages were also calculated and plotted for each parameter. Peptide charge was calculated using
the principles applied in the peptide property calculator from INNOVAGEN (Innovagen AB, Lund,
Sweden), which is based on pKa values of individual AAs [87]. At neutral pH, the following AAs
contribute to the peptide net charge (contribution given in parenthesis): Lys (+1), Arg (+1), His (+0.1),
Asp (−1), Glu (−1), and Cys (−0.07).
To evaluate variance of length, MW, and charge in the population distributions, the standard
deviation of weighted means was calculated as:
SD =
√√√∑n
p=1 Ip
(
xp − xavg
)2
(M−1)
M
∑n
p=1 Ip
(12)
where Ip is the intensity of peptide p, xp is the parameter observation for peptide p (e.g., PCLp), xavg is the
weighted population mean for the parameter (e.g., PCLavg), and M is the number of non-zero weights.
For simplicity in visualization, data were binned for histogram depiction. PCL was binned
with a bin size of 5 AAs (i.e., 3–7 AAs were binned and labeled as 5 AAs, etc.). PMW was initially
binned around each 100 Da (i.e., all peptides with 150 < PMW < 249.9999 were all labelled as
PMW = 200 Da, and subsequently binned again around each 500 Da (i.e., 150 < PMW < 749.9999
was labelled PMW = 500, 750 < PMW < 1249.9999 was labelled PMW = 1000 Da etc.). Due to low
occupancy in the upper bins, all peptides with PMW > 4250 Da are represented in the PMW = 4500 Da
bin. Pz was initially binned around each integer charge (i.e., all peptides with −0.5 < Pz < 0.49 were
labelled as Pz = 0, etc.) and, subsequently, the most extreme charge states were binned (i.e., Pz < −6.51
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were all labeled as Pz = −7 and Pz > 2.5 were all labelled as Pz = 3). Histograms of PCL, PMW, and Pz
distributions were plotted in OriginPro 8.5.0 SR1 (OriginLab Corporation, Northampton, MA, USA)
and figures assembled in their final form using INKSCAPE version 0.92.3 [88].
3.7.2. Prediction of Emulsification Activity
The computational prediction of emulsifying properties was performed using the EmulsiPred
algorithm described by [44], an improved version of an existing method [89], which is freely
available [90]. To give a short overview, three different emulsifier scores, namely sα, sβ, and sγ,
are computed based on the sequence of peptides, based on the potential ability of the peptide to assume
an α-helix, β-strand, or undefined conformation at the oil–water interface, respectively. The only
difference with the original algorithm is that the score for a generic peptide p is normalized based on
the following formula:
zi =
si − µ(si)
σ(si)
(13)
where si is one of the scores sα, sβ, or sγ, calculated for p, and µ(si) and σ(si) are the mean and the
standard deviation of the same score, calculated from a population of 40,000 peptides of the same
length as p. The emulsifying scores are therefore normalized around 0, with positive normalized scores
for emulsifying scores higher than the average and negatives normalized scores for emulsifying scores
lower than the average. This normalization procedure assures that scores obtained from peptides of
different length have a similar distribution and can be more easily compared. Emulsifying activity was
predicted for the 100 most abundant peptides (by peptide MS1 intensity) for each FPH sample fulfilling
a requirement of PCL > 6 (requirement to form any well-defined secondary structure at the interphase).
3.7.3. Prediction of Antioxidant Activity
For the computational predictions of antioxidant peptides, the AnOxPePred webserver (available at
http://services.bioinformatics.dtu.dk/service.php?AnOxPePred-1.0) was used [77]. This predictor is
based on a machine learning approach trained on a free radical scavenger (FRS) and metal chelating data
(MCA) set, with its predictions being from 0 (not antioxidant) to 1 (antioxidant). Antioxidant activity
was predicted for the 100 most abundant peptides (by peptide MS1 intensity) for each FPH sample
fulfilling a requirement of PCL ≤ 30.
3.8. Statistical Analysis
The current study was performed in a complete randomized block design test and obtained data
were analyzed in one-way ANOVA using STATGRAPHICS (version 18.1.06 The Planis, VA, USA).
Multiple comparison among means was calculated in Tukey HSD as a post-hoc test, while setting the
confidence level at 95%.
4. Conclusions
Short time enzymatic hydrolysis of a cod frame by application of Neut and Alc, individually or
sequentially, released peptides from minced cod frame and heated cod meat, showing promising
interfacial activity and antioxidative properties. Using a novel proteomic approach, we were able to
determine a number of weighted bulk attributes of the hydrolysates as well as an in-depth peptide-level
characterization. Combined with bioinformatic prediction of peptide functionality in a hitherto unseen
way, we were able to identify a number of highly specific peptides, which are both highly abundant
and predicted with high probability as being key in the observed activity. We observed a general
and surprising trend that increased hydrolysis did in fact increase emulsifying activity. Nevertheless,
this observation correlated with two highly abundant peptides (IIAPPERKYS and GADPEDVIVA)
with a high potential as γ-emulsifiers (containing both a hydrophobic and a hydrophilic region).
Furthermore, we identified a number of peptides that are highly likely to have emulsifying activity in
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a well-defined, secondary structure, in particular one β-strand emulsifier (DIDIRKDLYAN), which are
all promising leads. We also identified a number of peptides, predicted to have antioxidant properties
in vitro, although some substrate-specific differences were observed, which might be related to the
presence of residual bone in the minced cod frame. Our results demonstrate that using both proteomics
analysis and bioinformatic prediction is of great value when characterizing protein hydrolysates for
use in food and feed.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/18/12/599/s1,
Table S1: Combinatorial space of peptides as a function of length for peptides consisting of merely the 20
naturally occurring and unmodified L-amino acids (n = 20) and for peptides including the default variable
modifications from MaxQuant i.e., Met oxidation and N-terminal peptide alkylation (n = 21 + 1). Table S2:
Sequences, relative intensity, and predicted emulsifying activity in α-helical, β-strand, and γ (axial amphiphilicity)
conformation for the 100 peptides with highest relative intensity (PCL > 6) from enzymatically derived FPH
from minced cod frame (MCF) and heated cod meat (HCM). Table S3: All peptide data from proteomics analysis
including relative intensities, weighted length, weighted charge, weighted molecular weight, weighted AA
distribution, and in sample ranking (by intensity) (the table is appended separately as an .xlsx file). Table S4:
Sequences, relative intensity, and predicted free radical scavenging and (FRS) metal chelating activity (MCA)
scores for the 100 peptides with highest relative intensity from enzymatically derived FPH from minced cod frame
(MCF) and heated cod meat (HCM). Figure S1: SDS-PAGE of FPH samples on 4–20% gradient gels. A: 20 µg
protein/peptide [2]. B: 200 µg protein/peptide [2]. L (MW marker), 1 (MCF-Alc), 2 (MCF-Neut), 3 (MCF-Neut&Alc),
4 (HCM-Alc), 5 (HCM-Neut) and 6 (HCM-Neut&Alc). Figure S2: Histograms of binned, relative distributions for
peptide chain length (A + D), peptide molecular weight (B + E), and peptide charge at pH = 7 (C + F) for fish
protein hydrolysates obtained from minced cod frame (MCF) and heated cod meat (HCM) by enzymatic hydrolysis
with neutrase (Neut), alcalase (Alc) or sequential hydrolysis with neutrase and alcalase (Neut&Alc). Distributions
are shown for intensity-weighted data (A–C) and unweighted data (D–F). The proteomics data presented in this
study (raw MS data, MaxQuant txt output folder, and processed data (Table S3)) are openly available in Mendeley
Data at http://dx.doi.org/10.17632/pc5h9drk6d.2 [91].
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